Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
EGOH 0.0002 0 477600524
TNEN 0.0002 100 217443164
CEHC 0.0002 0 100999295
GERS 0.0002 0 84816124
SUTI 0.0002 -33.33 63944516
SUTI 0.0002 -33.33 63944516
GDSM 0.0002 0 59496919
SFMI 0.0002 0 37495000
INOH 0.0002 0 36115868
MDCE 0.0002 100 31652418
GBGM 0.0002 0 29652996
FOGC 0.0002 0 28214668
UMNG 0.0002 0 25549076
EPAZ 0.0002 0 23473928
HJOEE 0.0002 0 23228642
RIGH 0.0002 0 22753801
NSAV 0.0002 0 20000000
AFPW 0.0002 -0 18522446
CRPZ 0.0002 0 17250080
PPJE 0.0002 -0 14656000
ZNTR 0.0002 0 12500000
TADF 0.0002 0 12042000
UNGS 0.0002 0 11855000
YTRV 0.0002 0 11849998
RFMK 0.0002 0 10221000
QASP 0.0002 0 10160301
PMBS 0.0002 0 9456485
VSHC 0.0002 0 9000069
WNTR 0.0002 -0 6753650
SSPT 0.0002 0 6717273

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last